Carboplatin With Following Taxol Therapy Under Additional Application of Epoetin Alfa (ERYPO) With Female Patients With Advanced Ovarian Cancer FIGO IA/G3 - IV
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Epoetin alfa (Primary) ; Paclitaxel (Primary) ; Carboplatin
- Indications Ovarian cancer
- Focus Therapeutic Use
- 28 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Oct 2005 New trial record.